Atherosclerosis, Biological and Pathological Basis

  • Michele Porcu
  • Eytan Raz
  • Luca Saba
Living reference work entry


Atherosclerosis is a extremely complicated and still well not perfectly understood pathologic process that involves the arteries of the human body. It is a multi-step process that starts with the endothelial damage and can be influenced by many factors, modifiable or not. The definition of the grade of stenosis determined by an atherosclerotic plaque and the identification of vulnerable plaques are the main goals for diagnosis, staging and therapies.


Pathogenesis Risk factors Nitric Oxide (NO) Vulnerable plaque 


  1. 1.
    Douglas G et al (2010) The pathogenesis of atherosclerosis. Medicine 42:9; 38(8):397–402Google Scholar
  2. 2.
    Tao W et al (2012) Atherosclerosis: pathogenesis and pathology. Diagn Histopathol 18(11):461–492CrossRefGoogle Scholar
  3. 3.
    Balboni GC et al (2004) Anatomia Umana (terza edizione, tomo I, chapter 3). Edi.Ermes s.r.l., MilanoGoogle Scholar
  4. 4.
    Rindi G et al (2005) Fisiologia Umana (IX edizione). UTET S.p.A. Divisione scienze mediche, Corso Raffaello, TorinoGoogle Scholar
  5. 5.
    Hopkins PN (2013) Molecular biology of atherosclerosis. Physiol Rev 93:1317–1542. doi:10.1152/physrev.00004.2012CrossRefPubMedGoogle Scholar
  6. 6.
    Ignarro LJ et al (1987) Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci U S A 84(24):9265–9269CrossRefPubMedCentralPubMedGoogle Scholar
  7. 7.
    Vanhoutte PM (2009) Endothelial dysfunction; the first step toward coronary arteriosclerosis. Circ J 73:595e601CrossRefGoogle Scholar
  8. 8.
    Deanfield JE, Halcox JP, Rabelink TJ (2007) Endothelial function and dysfunction: testing and clinical relevance. Circulation 115:1285e95Google Scholar
  9. 9.
    Sima AV, Stancu CS, Simionescu M (2009) Vascular endothelium in atherosclerosis. Cell Tissue Res 335:191e203CrossRefGoogle Scholar
  10. 10.
    Whayne TF Jr (2011) Atherosclerosis: current status of prevention and treatment. Int J Angiol 20(4):213–222. doi:10.1055/s-0031-1295520CrossRefPubMedCentralPubMedGoogle Scholar
  11. 11.
    Tsimikas S, Miller YI (2011) Oxidative modification of lipoproteins: mechanisms, role in inflammation and potential clinical applications in cardiovascular disease. Curr Pharm Des 17:27e37CrossRefGoogle Scholar
  12. 12.
    Doran AC, Meller N, McNamara CA (2008) Role of smooth muscle cells in the initiation and early progression of atherosclerosis. Arterioscler Thromb Vasc Biol 28:812e9CrossRefGoogle Scholar
  13. 13.
    Heissig B, Hattori K, Friedrich M, Rafii S, Werb Z (2003) Angiogenesis: vascular remodeling of the extracellular matrix involves metalloproteinases. Curr Opin Hematol 10:136e41CrossRefGoogle Scholar
  14. 14.
    Visse R, Nagase H (2003) Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res 92:827e39CrossRefGoogle Scholar
  15. 15.
    Dhore CR, Cleutjens JP, Lutgens E et al (2001) Differential expression of bone matrix regulatory proteins in human atherosclerotic plaques. Arterioscler Thromb Vasc Biol 21:1998e2003CrossRefGoogle Scholar
  16. 16.
    Mishra TK et al (2013) An approach to the classification, diagnosis and management of vulnerable plaque. J Indian College Cardiol 3:57–66CrossRefGoogle Scholar
  17. 17.
    Virmani R, Burke AP, Kolodgie FD, Farb A (2002) Vulnerable plaque: the pathology of unstable coronary lesions. J Interv Cardiol 15:439e446CrossRefGoogle Scholar
  18. 18.
    Depre C, Havaux X, Wijns W (1996) Neovascularization in human coronary atherosclerotic lesions. Cathet Cardiovasc Diagn 39:215e220CrossRefGoogle Scholar
  19. 19.
    Sun Z et al (2012) Coronary CT angiography: current status and continuing challenges. Br J Radiol 85:495–510CrossRefPubMedCentralPubMedGoogle Scholar
  20. 20.
    Yang J et al (2013) MR and targeted molecular MRI of vulnerable plaques. Interv Neurol 1(3–4):124–131. doi:10.1159/000346767PubMedCentralPubMedGoogle Scholar
  21. 21.
    Kovárník T et al (2014) Current status of intravascular ultrasound in interventional cardiology. Vnitr Lek 60(12):1062–1067PubMedGoogle Scholar
  22. 22.
    Biasucci LM, Biasillo G, Stefanelli A (2010) Inflammatory markers, cholesterol and statins: pathophysiological role and clinical importance. Clin Chem Lab Med 48:1685e91CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2015

Authors and Affiliations

  1. 1.Department of RadiologyAzienda Ospedaliero Universitaria (A.O.U.)Monserrato (Cagliari)Italy
  2. 2.Interventional Neuroradiology Section, Department of RadiologyNew York University School of MedicineNew YorkUSA

Personalised recommendations